Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MORRIS PLAINS, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that three abstracts have been accepted for presentation at the 2016 San Antonio Breast...
-
MORRIS PLAINS, N.J., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that the Company was honored by the Research & Development Council of New Jersey with...
-
MORRIS PLAINS, N.J., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today reported financial results for the first quarter ended September 30, 2016. The Company also...
-
MORRIS PLAINS, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that it will host a conference call and live audio webcast on Wednesday, November 2, 2016 at...
-
MORRIS PLAINS, N.J., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that it has engaged Greenhill & Co., Inc. (NYSE:GHL) to serve as a strategic advisor...
-
MORRIS PLAINS, N.J., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced the issuance of U.S. Patent 9,458,242 for additional claims under the patent family “Dosages...
-
MORRIS PLAINS, N.J., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) announced today that it has closed on a previously disclosed underwritten offering of 10,000,000 shares of...
-
MORRIS PLAINS, N.J., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that it has priced an underwritten offering of 10,000,000 shares of common stock and...
-
MORRIS PLAINS, N.J., Aug. 31, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that the Company will present at three upcoming investor conferences: Credit Suisse 2016...
-
MORRIS PLAINS, N.J., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that adding an inhibitor of ATP-binding cassette (ABC) transporters to sacituzumab...